Kaiyan Li

12PUBLICATIONS
1CO-AUTHORS
Gene and molecular therapyCancer diagnosisPredictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 01, 2025
Perfluorobutane-enhanced US Targeting M2 Tumor-associated Macrophages for Predicting Programmed Cell Death-1 Response in Hepatocellular Carcinoma.

Zhe Huang, Jia-Qi Yue, Rong-Hua Zhu

|Oct 31, 2024
Diagnostic performance of Sonazoid-enhanced CEUS in identifying definitive hepatocellular carcinoma in cirrhotic patients according to KLCA-NCC 2022 and APASL 2017 guidelines.

Zhe Huang, Rong-Hua Zhu, Shan-Shan Li

|Apr 01, 2024
CEUS in prediction of early recurrence of hepatocellular carcinoma after curative resection and to stratify the risk of early recurrence: a retrospective observational study.

Zhe Huang, Rong-Hua Zhu, Shan-Shan Li

|Sep 26, 2023
Dynamic contrast-enhanced ultrasonography with sonazoid predicts microvascular invasion in early-stage hepatocellular carcinoma.

Zhe Huang, Jun-Yi Xin, Ling-Ling Wu

|Mar 06, 2023
CEUS LI-RADS for diagnosis of hepatocellular carcinoma in individuals without LI-RADS-defined hepatocellular carcinoma risk factors.

Zhe Huang, Ping Ping Zhou, Shan Shan Li

|Dec 22, 2022
HCC treated with immune checkpoint inhibitors: a hyper-enhanced rim on Sonazoid-CEUS Kupffer phase images is a predictor of tumor response.

Zhe Huang, Rong-Hua Zhu, Jun-Yi Xin

Pageof 2

Frequent Collaborators

1 joint publications

Pin Lv